DK527585D0 - Monoethanolaminsaltet af n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxid paa saerlig krystallinsk form - Google Patents

Monoethanolaminsaltet af n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxid paa saerlig krystallinsk form

Info

Publication number
DK527585D0
DK527585D0 DK527585A DK527585A DK527585D0 DK 527585 D0 DK527585 D0 DK 527585D0 DK 527585 A DK527585 A DK 527585A DK 527585 A DK527585 A DK 527585A DK 527585 D0 DK527585 D0 DK 527585D0
Authority
DK
Denmark
Prior art keywords
benzothiazine
carboxamide
pyridyl
hydroxy
dioxide
Prior art date
Application number
DK527585A
Other languages
English (en)
Other versions
DK171726B1 (da
DK527585A (da
Inventor
Robert Lee Robertson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK527585D0 publication Critical patent/DK527585D0/da
Publication of DK527585A publication Critical patent/DK527585A/da
Application granted granted Critical
Publication of DK171726B1 publication Critical patent/DK171726B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16L—PIPES; JOINTS OR FITTINGS FOR PIPES; SUPPORTS FOR PIPES, CABLES OR PROTECTIVE TUBING; MEANS FOR THERMAL INSULATION IN GENERAL
    • F16L57/00—Protection of pipes or objects of similar shape against external or internal damage or wear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK527585A 1984-11-16 1985-11-15 Monoethanolaminsaltet af N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid på særlig krystallinsk form DK171726B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/672,028 US4582831A (en) 1984-11-16 1984-11-16 Anti-inflammatory polymorphic monoethanolamine salt of N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide compound, composition, and method of use therefor
US67202884 1984-11-16

Publications (3)

Publication Number Publication Date
DK527585D0 true DK527585D0 (da) 1985-11-15
DK527585A DK527585A (da) 1986-05-17
DK171726B1 DK171726B1 (da) 1997-04-14

Family

ID=24696846

Family Applications (1)

Application Number Title Priority Date Filing Date
DK527585A DK171726B1 (da) 1984-11-16 1985-11-15 Monoethanolaminsaltet af N-(2-pyridyl)-2-methyl-4-hydroxy-2H-1,2-benzothiazin-3-carboxamid-1,1-dioxid på særlig krystallinsk form

Country Status (28)

Country Link
US (1) US4582831A (da)
EP (1) EP0182572B1 (da)
JP (1) JPS61122284A (da)
KR (1) KR870000291B1 (da)
CN (1) CN1004001B (da)
AT (1) ATE50257T1 (da)
AU (1) AU556378B2 (da)
CA (1) CA1209572A (da)
DD (1) DD242405A5 (da)
DE (1) DE3575925D1 (da)
DK (1) DK171726B1 (da)
EG (1) EG17621A (da)
ES (1) ES8701712A1 (da)
FI (1) FI82045C (da)
GR (1) GR852772B (da)
HU (1) HU197899B (da)
IE (1) IE58288B1 (da)
IL (1) IL77051A (da)
IN (1) IN164207B (da)
MY (1) MY101984A (da)
NO (1) NO854574L (da)
NZ (1) NZ214201A (da)
PH (1) PH21322A (da)
PL (1) PL149466B1 (da)
PT (1) PT81490B (da)
SU (1) SU1491339A3 (da)
YU (1) YU44019B (da)
ZA (1) ZA858773B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5436241A (en) * 1994-01-14 1995-07-25 Bristol-Myers Squibb Company Topical anti-inflammatory compositions containing piroxicam
US20030068829A1 (en) * 2001-06-25 2003-04-10 Symyx Technologies, Inc. High throughput crystallographic screening of materials
TWI280128B (en) * 2002-05-22 2007-05-01 Smithkline Beecham Corp 3'-[(2Z)-[1-(3,4- dimethylphenyl)-1,5-dihydro-3-methyl-5-oxo-4H-pyrazol-4-ylidene]hydrazino]-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid bis-(monoethanolamine)
ECSP077628A (es) * 2007-05-03 2008-12-30 Smithkline Beechman Corp Nueva composición farmacéutica
BRPI1014548A2 (pt) 2009-05-29 2015-08-25 Glaxosmithkline Llc Métodos de administração de compostos agonistas de trombopoetina
ES2553114T3 (es) * 2009-07-29 2015-12-04 Nerviano Medical Sciences S.R.L. Sales de inhibidor de plk
GB0914287D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
IN160683B (da) * 1981-06-01 1987-07-25 Pfizer
US4434164A (en) * 1981-06-01 1984-02-28 Pfizer Inc. Crystalline benzothiazine dioxide salts
RO88420A (ro) * 1983-04-25 1986-01-30 Pfizer Inc,Us Procedeu pentru prepararea unor saruri bazice de piroxican depuse pe suporturi farmaceutice

Also Published As

Publication number Publication date
IL77051A0 (en) 1986-04-29
FI854512A0 (fi) 1985-11-15
ES548878A0 (es) 1986-12-01
EP0182572B1 (en) 1990-02-07
HU197899B (en) 1989-06-28
DK171726B1 (da) 1997-04-14
KR870000291B1 (ko) 1987-02-25
YU44019B (en) 1990-02-28
CA1209572A (en) 1986-08-12
JPH0425957B2 (da) 1992-05-06
US4582831A (en) 1986-04-15
EG17621A (en) 1991-08-30
IL77051A (en) 1989-03-31
MY101984A (en) 1992-02-29
FI82045B (fi) 1990-09-28
IE852852L (en) 1986-05-16
CN1004001B (zh) 1989-04-26
AU4995085A (en) 1986-05-22
YU178585A (en) 1987-12-31
DD242405A5 (de) 1987-01-28
PL149466B1 (en) 1990-02-28
JPS61122284A (ja) 1986-06-10
IN164207B (da) 1989-01-28
ZA858773B (en) 1987-06-24
FI82045C (fi) 1991-01-10
PH21322A (en) 1987-09-28
HUT40116A (en) 1986-11-28
DK527585A (da) 1986-05-17
CN85108245A (zh) 1986-09-03
NZ214201A (en) 1988-07-28
AU556378B2 (en) 1986-10-30
DE3575925D1 (de) 1990-03-15
PL256259A1 (en) 1986-10-07
NO854574L (no) 1986-05-20
IE58288B1 (en) 1993-08-25
PT81490A (en) 1985-12-01
ATE50257T1 (de) 1990-02-15
ES8701712A1 (es) 1986-12-01
FI854512A (fi) 1986-05-17
KR860004038A (ko) 1986-06-16
SU1491339A3 (ru) 1989-06-30
PT81490B (pt) 1988-03-03
GR852772B (da) 1986-03-14
EP0182572A1 (en) 1986-05-28

Similar Documents

Publication Publication Date Title
IE821286L (en) Crystalline benzothiazine dioxide salts
MX162676A (es) Procedimiento para la preparacion de derivados de 2-(piridilalquensulfinii.)benzimidazoles n-substituidos
DK13082A (da) Analogifremgangsmaade til fremstilling af n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxid-derivater
IE821287L (en) Water-soluble benzothiazine salts
PT72435B (pt) Process for the preparation of 2-<2-(1,4-benzodioxanyl)>-2-imi-dazoline and salts thereof having pharmaceutical effect
DK527585A (da) Monoethanolaminsaltet af n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxid paa saerlig krystallinsk form
DK416888A (da) Cephalosporinforbindelser, krystallinske derivater deraf, mellemprodukter til brug ved fremstilling af cephalosporinforbindelser og fremgangsmaader til fremstilling af cephalosporinforbindelser
DE3473443D1 (en) New amino derivatives of 2- (n-(2,2,5,5-tetramethyl-3-pyrrolin-or pyrrolidine-3-carbonyl))
NO890803D0 (no) Fremgangsmaate for fremstilling av trisubstituerte aminer.
FI943833A0 (fi) Menetelmä 2,3,5,6-tetraklooripyridiinin valmistamiseksi
DK193580A (da) Fremgangsmaade til fremstilling af 5-(2-( (2,3-dihydro-1,4-benzodioxan-2-yl-methyl)amino)-1-hydroxyethyl)-2-hydroxybenzoesyre-derivater
BR8801794A (pt) Composicao fungicida e processo para a preparacao de derivados de 2-(o-alquila/substituido/)-2-tio-1,3,2-oxatiofosfolano
SE8404553L (sv) Kristallina bensotiazindioxidsalter
DE68910444T2 (de) 2-(1-Pentyl-3-guanidino)-4-(2-methyl-4-imidazolyl)-Thiazol-Hemiphosphat-Hemihydrat.
YU42871B (en) Process for the manufacture of n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide
YU42848B (en) Process for the manufacture of n-(2-pyridyl)-2-alkyl-4-hydroxy-2h-1,2-benzothiazine-3-carboxamide-1,1-dioxide
ES525558A0 (es) Un procedimiento para la preparacion de derivados de 1,1-dioxido de n-(2-piridil)-2-metil-4-hidroxi-2h-1,2-benzotiazin-3-carboxamida
FI92395C (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten sulfonamidien valmistamiseksi

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK